Schicho R - Search Results

1

Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy.

Schicho R, Nazyrova A, Shaykhutdinov R, Duggan G, Vogel HJ, Storr M. Schicho R, et al. J Proteome Res. 2010 Dec 3;9(12):6265-73. doi: 10.1021/pr100547y. Epub 2010 Oct 28. J Proteome Res. 2010. PMID: 20886908

2

Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals.

Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, Kaplan GG, Vogel HJ, Storr M. Schicho R, et al. J Proteome Res. 2012 Jun 1;11(6):3344-57. doi: 10.1021/pr300139q. Epub 2012 May 17. J Proteome Res. 2012. PMID: 22574726 Free PMC article.

3

Cardiovascular complications in inflammatory bowel disease.

Schicho R, Marsche G, Storr M. Schicho R, et al. Curr Drug Targets. 2015;16(3):181-8. doi: 10.2174/1389450116666150202161500. Curr Drug Targets. 2015. PMID: 25642719 Free PMC article. Review.

4

Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice.

Schicho R, Storr M. Schicho R, et al. Pharmacology. 2012;89(3-4):149-55. doi: 10.1159/000336871. Epub 2012 Mar 12. Pharmacology. 2012. PMID: 22414698 Free PMC article.

5

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.

Schicho R, Bashashati M, Bawa M, McHugh D, Saur D, Hu HM, Zimmer A, Lutz B, Mackie K, Bradshaw HB, McCafferty DM, Sharkey KA, Storr M. Schicho R, et al. Inflamm Bowel Dis. 2011 Aug;17(8):1651-64. doi: 10.1002/ibd.21538. Epub 2010 Nov 15. Inflamm Bowel Dis. 2011. PMID: 21744421 Free PMC article.

6

Metabolomics: is it useful for inflammatory bowel diseases?

Storr M, Vogel HJ, Schicho R. Storr M, et al. Among authors: schicho r. Curr Opin Gastroenterol. 2013 Jul;29(4):378-83. doi: 10.1097/MOG.0b013e328361f488. Curr Opin Gastroenterol. 2013. PMID: 23624676 Free PMC article. Review.

7

Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies.

Schicho R, Storr M. Schicho R, et al. Expert Rev Clin Pharmacol. 2010 Mar;3(2):193-207. doi: 10.1586/ecp.09.62. Expert Rev Clin Pharmacol. 2010. PMID: 22111567

8

A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.

Li K, Fichna J, Schicho R, Saur D, Bashashati M, Mackie K, Li Y, Zimmer A, Göke B, Sharkey KA, Storr M. Li K, et al. Among authors: schicho r. Neuropharmacology. 2013 Aug;71(100):255-63. doi: 10.1016/j.neuropharm.2013.03.029. Epub 2013 Apr 18. Neuropharmacology. 2013. PMID: 23603203 Free PMC article.

9

Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.

Schicho R, Storr M. Schicho R, et al. Can J Gastroenterol. 2011 Jul;25(7):377-83. doi: 10.1155/2011/953975. Can J Gastroenterol. 2011. PMID: 21876860 Free PMC article. Review.

10

A potential role for GPR55 in gastrointestinal functions.

Schicho R, Storr M. Schicho R, et al. Curr Opin Pharmacol. 2012 Dec;12(6):653-8. doi: 10.1016/j.coph.2012.09.009. Epub 2012 Oct 10. Curr Opin Pharmacol. 2012. PMID: 23063456 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters